Neutrophils as a pallbearer for SARS-CoV-2 disease burden - Authors' reply.
作者信息
Lutter René, Schurink Bernadette, Roos Eva, Guo Lihui, van der Valk Paul, Bugiani Marianna
机构信息
Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands.
Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam 1105 AZ, The Netherlands.
出版信息
Lancet Microbe. 2021 Feb;2(2):e57. doi: 10.1016/S2666-5247(21)00001-X. Epub 2021 Feb 2.
Abstract
摘要
相似文献
1
Neutrophils as a pallbearer for SARS-CoV-2 disease burden - Authors' reply.
Lancet Microbe. 2021 Feb;2(2):e57. doi: 10.1016/S2666-5247(21)00001-X. Epub 2021 Feb 2.
2
Neutrophils as a pallbearer for SARS-CoV-2 disease burden.
Lancet Microbe. 2021 Feb;2(2):e56. doi: 10.1016/S2666-5247(21)00002-1. Epub 2021 Feb 2.
3
The ability of the neonatal immune response to handle SARS-CoV-2 infection - Authors' reply.
Lancet Child Adolesc Health. 2021 Mar;5(3):e8. doi: 10.1016/S2352-4642(21)00004-3. Epub 2021 Jan 21.
4
Activation of Type I and Type II Interferon Signaling in SARS-CoV-2-Positive Thyroid Tissue of Patients Dying from COVID-19.
Thyroid. 2021 Dec;31(12):1766-1775. doi: 10.1089/thy.2021.0345.
5
Toward a clinically based classification of disease severity for paediatric COVID-19 - Authors' reply.
Lancet Infect Dis. 2021 Jan;21(1):22-23. doi: 10.1016/S1473-3099(20)30397-2. Epub 2020 May 15.
6
Authors' Reply.
J Am Soc Nephrol. 2020 Sep;31(9):2225-2226. doi: 10.1681/ASN.2020060847. Epub 2020 Aug 12.
7
ECMO support for COVID-19: a balancing act - Authors' reply.
Lancet. 2021 Jan 9;397(10269):95. doi: 10.1016/S0140-6736(20)32517-4.
8
Microvascular disease in diabetes and severe COVID-19 outcomes - Authors' reply.
Lancet Diabetes Endocrinol. 2021 Apr;9(4):201. doi: 10.1016/S2213-8587(21)00055-3.
9
Using the neutrophil-to-lymphocyte ratio to estimate the severity of coronavirus disease 2019. Authors' reply.
Pol Arch Intern Med. 2020 Aug 27;130(7-8):717-718. doi: 10.20452/pamw.15582.
10
Pathophysiology of COVID-19-associated acute respiratory distress syndrome - Authors' reply.
Lancet Respir Med. 2021 Jan;9(1):e5-e6. doi: 10.1016/S2213-2600(20)30525-7. Epub 2020 Nov 13.
引用本文的文献
1
Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19.
J Pathol. 2022 Mar;256(3):256-261. doi: 10.1002/path.5842. Epub 2022 Jan 10.
本文引用的文献
1
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19.
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):988-994. doi: 10.1161/ATVBAHA.120.315267. Epub 2020 Dec 3.
2
Rhinovirus-16 induced temporal interferon responses in nasal epithelium links with viral clearance and symptoms.
Clin Exp Allergy. 2019 Dec;49(12):1587-1597. doi: 10.1111/cea.13481. Epub 2019 Oct 31.
3
IL-33 drives influenza-induced asthma exacerbations by halting innate and adaptive antiviral immunity.
J Allergy Clin Immunol. 2019 Apr;143(4):1355-1370.e16. doi: 10.1016/j.jaci.2018.08.051. Epub 2018 Oct 12.
4
High Level of Neutrophil Extracellular Traps Correlates With Poor Prognosis of Severe Influenza A Infection.
J Infect Dis. 2018 Jan 17;217(3):428-437. doi: 10.1093/infdis/jix475.
5
Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation.
Nat Med. 2017 Jun;23(6):681-691. doi: 10.1038/nm.4332. Epub 2017 May 1.
Zotero 插件